EU fines AstraZeneca €60m

European Union antitrust regulators today fined British pharmaceutical company AstraZeneca €60m for keeping prices on its ulcer drug product artificially high.

European Union antitrust regulators today fined British pharmaceutical company AstraZeneca €60m for keeping prices on its ulcer drug product artificially high.

EU spokesman Jonathan Todd said the company infringed EU competition rules between 1993 and 2000.

You have reached your article limit. Already a subscriber? Sign in

Unlimited access starts here.

Try from only €0.25 a day.

Cancel anytime

More in this section

The Business Hub

Newsletter

News and analysis on business, money and jobs from Munster and beyond by our expert team of business writers.

Cookie Policy Privacy Policy Brand Safety FAQ Help Contact Us Terms and Conditions

© Examiner Echo Group Limited